Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Closing the clinical-radiological paradox using the visual pathway in multiple sclerosis.
Miscellaneous indications for extracorporeal photochemotherapy (ECP).
The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
Dendritic cells and multiple sclerosis: disease, tolerance and therapy.
Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6.
Activation of CD4(+) Foxp3(+) regulatory T cells proceeds normally in the absence of B cells during EAE.
[Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature.]
Flash Pulmonary Edema in Multiple Sclerosis.
[Neuromyelitis optica and anti-aquaporin 4 antibody].
Cystoid macular oedema after fingolimod treatment in multiple sclerosis.
Discovery of Dual Leucine Zipper Kinase (DLK, MAP3K12) Inhibitors with Activity in Neurodegeneration Models.
Retinal architecture and mfERG: Optic nerve head component response characteristics in MS.
[Clinical validity of the quantitative gait variables in patients with multiple sclerosis. A comparison of the Timed 25-foot Walk Test and the GAITRite ® Electronic Walkway system].
On the sex ratio of multiple sclerosis.
High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: A case report and brief review of literature.
Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis optica.
Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.
Myelination of rodent hippocampal neurons in culture.
Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord.
Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.
Origin and differentiation of microglia.
Association Between Glutamate Blockade and Fatigue in Patients With Multiple Sclerosis.
Innate and adaptive immunity in the development of depression: An update on current knowledge and technological advances.
Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis.
Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.
Pages
« first
‹ previous
…
246
247
248
249
250
251
252
253
254
…
next ›
last »